FLGT – Fulgent Genetics, Inc.

Fulgent Genetics, Inc.

FLGT

$18.53

Name : Fulgent Genetics, Inc.

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $564,119,936.00

EPSttm : -1.66

Fulgent Genetics, Inc.

$18.53

7.86%

$1.35

Float Short %

9.5

Margin Of Safety %

Put/Call OI Ratio

0.06

EPS Next Q Diff

-0.24

EPS Last/This Y

0.86

EPS This/Next Y

-0.08

Price

18.53

Target Price

21.5

Analyst Recom

2.67

Performance Q

7.42

Relative Volume

3.71

Beta

0.83

Ticker: FLGT

20 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-07-07	FLGT	19.26	0.03	0.12	19121
2025-07-08	FLGT	19.52	0.04	0.04	19113
2025-07-09	FLGT	19.57	0.04	0.48	19141
2025-07-10	FLGT	19.54	0.04	0.09	19165
2025-07-11	FLGT	19.26	0.04	0.00	19273
2025-07-14	FLGT	19.13	0.04	0.35	19271
2025-07-15	FLGT	18.05	0.04	0.25	19324
2025-07-16	FLGT	18.02	0.06	0.06	18869
2025-07-17	FLGT	18.14	0.06	0.02	19121
2025-07-18	FLGT	17.79	0.06	0.18	19131
2025-07-21	FLGT	17.77	0.06	0.07	13217
2025-07-22	FLGT	18.66	0.06	0.06	13537
2025-07-23	FLGT	18.87	0.06	0.03	13566
2025-07-24	FLGT	18.4	0.06	0.00	13771
2025-07-25	FLGT	18.38	0.06	0.05	13271
2025-07-28	FLGT	18.02	0.06	0.01	13300
2025-07-29	FLGT	17.58	0.06	0.00	13408
2025-07-30	FLGT	17.5	0.06	0.01	13451
2025-07-31	FLGT	17.16	0.06	0.04	13529
2025-08-01	FLGT	18.52	0.06	0.25	15577
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-07-07	FLGT	19.30	-223.2	22.1	-0.55
2025-07-08	FLGT	19.52	-223.2	17.4	-0.55
2025-07-09	FLGT	19.58	-223.2	18.2	-0.55
2025-07-10	FLGT	19.55	-223.2	18.7	-0.55
2025-07-11	FLGT	19.27	-223.2	20.0	-0.55
2025-07-14	FLGT	19.12	-223.2	19.4	-0.55
2025-07-15	FLGT	18.07	-223.2	23.9	-0.55
2025-07-16	FLGT	18.04	-223.2	18.7	-0.55
2025-07-17	FLGT	18.13	-223.2	18.0	-0.55
2025-07-18	FLGT	17.77	-223.2	20.7	-0.55
2025-07-21	FLGT	17.75	-223.2	18.7	-0.55
2025-07-22	FLGT	18.66	-223.2	13.0	-0.55
2025-07-23	FLGT	18.88	-223.2	17.2	-0.55
2025-07-24	FLGT	18.41	-223.2	21.1	-0.55
2025-07-25	FLGT	18.37	-223.2	18.8	-0.55
2025-07-28	FLGT	17.99	-223.2	20.6	-0.55
2025-07-29	FLGT	17.57	-223.2	21.2	-0.55
2025-07-30	FLGT	17.49	-223.2	19.1	-0.55
2025-07-31	FLGT	17.18	-223.2	20.5	-0.55
2025-08-01	FLGT	18.53	-223.2	9.6	-0.55
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-07-07	FLGT	0.89	-12.57	8.40
2025-07-08	FLGT	0.89	-12.57	8.40
2025-07-09	FLGT	0.89	-12.57	8.40
2025-07-10	FLGT	0.89	-12.57	8.40
2025-07-11	FLGT	0.89	-12.57	9.82
2025-07-14	FLGT	0.89	-12.20	9.82
2025-07-15	FLGT	0.89	-12.20	9.82
2025-07-16	FLGT	0.89	-12.20	9.82
2025-07-17	FLGT	0.89	-12.20	9.82
2025-07-18	FLGT	0.89	-12.20	9.82
2025-07-21	FLGT	0.89	-12.16	9.82
2025-07-22	FLGT	0.89	-12.16	9.82
2025-07-23	FLGT	0.89	-12.16	9.82
2025-07-24	FLGT	0.89	-12.16	9.82
2025-07-25	FLGT	0.89	-12.16	9.50
2025-07-28	FLGT	0.89	-13.34	9.50
2025-07-29	FLGT	0.89	-13.34	9.50
2025-07-30	FLGT	0.89	-13.34	9.50
2025-07-31	FLGT	0.89	-13.34	9.50
2025-08-01	FLGT	0.89	-13.34	9.50
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.04

Avg. EPS Est. Current Quarter

-0.18

Avg. EPS Est. Next Quarter

-0.2

Insider Transactions

0.89

Institutional Transactions

-13.34

Beta

0.83

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

90.2

Max Drawdown 5-Year %

-91.7

Target Price

21.5

P/E

Forward P/E

PEG

P/S

1.93

P/B

0.5

P/Free Cash Flow

EPS

-1.34

Average EPS Est. Cur. Y

-0.55

EPS Next Y. (Est.)

-0.63

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-13.94

Relative Volume

3.71

Return on Equity vs Sector %

-27.4

Return on Equity vs Industry %

-14.1

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.1

EBIT Estimation

9.6

Fulgent Genetics, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 1313

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is headquartered in El Monte, California.

stock quote shares FLGT – Fulgent Genetics, Inc. Stock Price stock today

news today FLGT – Fulgent Genetics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch FLGT – Fulgent Genetics, Inc. yahoo finance google finance

stock history FLGT – Fulgent Genetics, Inc. invest stock market

stock prices FLGT premarket after hours

ticker FLGT fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

FLGT – Fulgent Genetics, Inc.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: FLGT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y